Literature DB >> 31532996

Specific Recognition of Promoter G-Quadruplex DNAs by Small Molecule Ligands and Light-up Probes.

V Dhamodharan1,2, P I Pradeepkumar1.   

Abstract

G-Quadruplexes (G4s) are four-stranded nucleic acid structures whose underlying G-rich sequences are present across the chromosome and transcriptome. These highly structured elements are known to regulate many key biological functions such as replication, transcription, translation, and genomic stability, thereby providing an additional layer of gene regulation. G4s are structurally dynamic and diverse, and they can fold into numerous topologies. They are potential targets for small molecules, which can modulate their functions. To this end, myriad classes of small molecules have been developed and studied for their ability to bind and stabilize these unique structures. Though many of them can selectively target G4s over duplex DNA, only a few of them can distinguish one G4 topology from others. Design and development of G4-specific ligands are challenging owing to the subtle structural variations among G4 structures. However, screening assays and computational methods have identified a few classes of ligands that preferentially or specifically target the G4 topology of interest over others. This review focuses on the small molecules and fluorescent probes that specifically target human promoter G4s associated with oncogenes. Targeting promoter G4s could circumvent the issues such as undruggability and development of drug resistance associated with the protein targets. The ligands discussed here highlight that development of G4-specific ligands is an achievable goal in spite of the limited structural data available. The future goal is to pursue the development of G4-specific ligands endowed with drug-like properties for G4-based therapeutics and diagnostics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31532996     DOI: 10.1021/acschembio.9b00475

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  6 in total

1.  Drug discovery of small molecules targeting the higher-order hTERT promoter G-quadruplex.

Authors:  Robert C Monsen; Jon M Maguire; Lynn W DeLeeuw; Jonathan B Chaires; John O Trent
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

2.  Synthesis and investigation of quadruplex-DNA-binding, 9-O-substituted berberine derivatives.

Authors:  Jonas Becher; Daria V Berdnikova; Heiko Ihmels; Christopher Stremmel
Journal:  Beilstein J Org Chem       Date:  2020-11-18       Impact factor: 2.883

3.  Evaluating the Influence of a G-Quadruplex Prone Sequence on the Transactivation Potential by Wild-Type and/or Mutant P53 Family Proteins through a Yeast-Based Functional Assay.

Authors:  Paola Monti; Vaclav Brazda; Natália Bohálová; Otília Porubiaková; Paola Menichini; Andrea Speciale; Renata Bocciardi; Alberto Inga; Gilberto Fronza
Journal:  Genes (Basel)       Date:  2021-02-15       Impact factor: 4.096

4.  A high-throughput screening to identify small molecules that suppress huntingtin promoter activity or activate huntingtin-antisense promoter activity.

Authors:  Hongxuan Feng; Xin Hu; Xin Sun; Wang Zheng; Houda G Khaled; Pan P Li; Dobrila D Rudnicki; Wenjuan Ye; Yu-Chi Chen; Noel Southall; Juan Marugan; Christopher A Ross; Marc Ferrer; Mark J Henderson; Russell L Margolis
Journal:  Sci Rep       Date:  2021-03-17       Impact factor: 4.379

5.  In situ formation of transcriptional modulators using non-canonical DNA i-motifs.

Authors:  Puja Saha; Deepanjan Panda; Diana Müller; Arunabha Maity; Harald Schwalbe; Jyotirmayee Dash
Journal:  Chem Sci       Date:  2020-02-18       Impact factor: 9.825

6.  Recognition of G-quadruplex topology through hybrid binding with implications in cancer theranostics.

Authors:  Yelisetty Venkata Suseela; Pardhasaradhi Satha; N Arul Murugan; Thimmaiah Govindaraju
Journal:  Theranostics       Date:  2020-08-20       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.